Ubcare Posts 7.5 Billion Won Operating Profit Last Year, Up 46% Year-on-Year

"Results from Transition to a High-Profit Structure"
Improved Profit Structure for Hospitals, Clinics, and Pharmacies
Targeting 80% Operating Profit Growth This Year

On February 2, digital healthcare platform company Ubcare announced that its consolidated sales for the previous year reached 197.7 billion won, with an operating profit of 7.5 billion won. These figures represent increases of 3.7% and 45.7%, respectively, compared to the previous year.

Ubcare stated, "While revenue continues to grow steadily, the company has begun to see results from a shift to a profit-focused business structure, achieving a transition to a 'high-profit structure.'"

The key driver of improved performance was the optimization of the profit structure for its main platform business targeting hospitals, clinics, and pharmacies. In the hospital and clinic segment, profit increased by more than 50% year-on-year, thanks to the normalization of consignment service profitability and improved efficiency in agency operations. The pharmacy segment also established a stable profit base by expanding high-value-added services centered on its main service, "Upharm," and increasing the number of prescriptions and dispensations. Increases in average transaction value and improvements to the commission structure also contributed to the results.

Ubcare has set 2026 as a clear turning point for a rebound in performance, aiming for "over 80% year-on-year growth in operating profit." The company plans to expand its lineup of high-profit services centered on its core electronic medical record (EMR) business and to supply more high-value-added solutions to improve the operational efficiency of hospitals, clinics, and pharmacies. In the first half of the year, it will introduce artificial intelligence (AI)-based solutions designed to simultaneously enhance on-site work efficiency and added value.

An Ubcare representative said, "Through ongoing responsible management and business advancement, we will continue to increase both corporate and shareholder value."

This content was produced with the assistance of AI translation services.